Ng, C., Chowbay, B., Choo, S. P., Tai, D., Somasundaram, N., Yu, Y., . . . Chang, Y. (2016). P-121 Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer. Ann Oncol.

Ng, C., B. Chowbay, S. P. Choo, D. Tai, N. Somasundaram, Y. Yu, S. Lam, und Y. Chang. "P-121 Phase Ib Trial of Oxaliplatin, UGT1A1 Genotype-directed Dosing of Irinotecan and Chronomodulated Capecitabine (OXIRI) Chemotherapy in Patients With Advanced Pancreatic Cancer." Ann Oncol 2016.

Ng, C., et al. "P-121 Phase Ib Trial of Oxaliplatin, UGT1A1 Genotype-directed Dosing of Irinotecan and Chronomodulated Capecitabine (OXIRI) Chemotherapy in Patients With Advanced Pancreatic Cancer." Ann Oncol 2016.